title: Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.
abstract: The density of native (preexisting) collaterals and their capacity to enlarge into large conduit arteries in ischemia (arteriogenesis) are major determinants of the severity of tissue injury in occlusive disease. Mechanisms directing arteriogenesis remain unclear. Moreover, nothing is known about how native collaterals form in healthy tissue. Evidence suggests vascular endothelial growth factor (VEGF), which is important in embryonic vascular patterning and ischemic angiogenesis, may contribute to native collateral formation and arteriogenesis. Therefore, we examined mice heterozygous for VEGF receptor-1 (VEGFR-1(+/-)), VEGF receptor-2 (VEGFR-2(+/-)), and overexpressing (VEGF(hi/+)) and underexpressing VEGF-A (VEGF(lo/+)). Recovery from hindlimb ischemia was followed for 21 days after femoral artery ligation. All statements below are P<0.05. Compared to wild-type mice, VEGFR-2(+/-) showed similar: ischemic scores, recovery of hindlimb perfusion, pericollateral leukocytes, collateral enlargement, and angiogenesis. In contrast, VEGFR-1(+/-) showed impaired: perfusion recovery, pericollateral leukocytes, collateral enlargement, worse ischemic scores, and comparable angiogenesis. Compared to wild-type mice, VEGF(lo/+) had 2-fold lower perfusion immediately after ligation (suggesting fewer native collaterals which was confirmed by angiography) and blunted recovery of perfusion. VEGF(hi/+) mice had 3-fold greater perfusion immediately after ligation, more native collaterals, and improved recovery of perfusion. These differences were confirmed in the cerebral pial cortical circulation where, compared to VEGF(hi/+) mice, VEGF(lo/+) formed fewer collaterals during the perinatal period when adult density was established, and had 2-fold larger infarctions after middle cerebral artery ligation. Our findings indicate VEGF and VEGFR-1 are determinants of arteriogenesis. Moreover, we describe the first signaling molecule, VEGF-A, that specifies formation of native collaterals in healthy tissues.
authors.affiliation: Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, NC 27599-7545, USA.
authors.forename: Jason A
authors.initials: JA
authors.lastname: Clayton
authors.forename: Dan
authors.initials: D
authors.lastname: Chalothorn
authors.forename: James E
authors.initials: JE
authors.lastname: Faber
mesh_terms: D000818:Animals; D002560:Cerebrovascular Circulation; D003097:Collateral Circulation; D004195:Disease Models, Animal; D005263:Femoral Artery / Q000601:surgery; D005838:Genotype; D020244:Infarction, Middle Cerebral Artery / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D007511:Ischemia / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D007962:Leukocytes / Q000473:pathology; D008026:Ligation; D051379:Mice; D008822:Mice, Transgenic; D018482:Muscle, Skeletal / Q000098:blood supply*; D018919:Neovascularization, Physiologic; D010641:Phenotype; D012039:Regional Blood Flow; D015398:Signal Transduction; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000378:metabolism*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000235:genetics / Q000378:metabolism
chemical_list: D042461:Vascular Endothelial Growth Factor A; C467480:vascular endothelial growth factor A, mouse; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2
references.citation: Dev Biol. 2003 Oct 15;262(2):225-41
references.pmid: 14550787
references.citation: Trends Biochem Sci. 2003 Sep;28(9):488-94
references.pmid: 13678960
references.citation: Circulation. 2004 Oct 19;110(16):2424-9
references.pmid: 15477417
references.citation: Physiol Genomics. 2007 Jul 18;30(2):179-91
references.pmid: 17426116
references.citation: Eur J Clin Invest. 2007 Oct;37(10):755-66
references.pmid: 17764463
references.citation: Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):322-8
references.pmid: 18079407
references.citation: Mol Biol Cell. 2008 Mar;19(3):994-1006
references.pmid: 18094043
references.citation: J Cell Mol Med. 2008 Aug;12(4):1284-302
references.pmid: 18266966
references.citation: Blood. 2004 Jun 15;103(12):4527-35
references.pmid: 14982871
references.citation: Nature. 1996 Apr 4;380(6573):435-9
references.pmid: 8602241
references.citation: Nature. 1996 Apr 4;380(6573):439-42
references.pmid: 8602242
references.citation: Am J Physiol. 1996 Oct;271(4 Pt 1):C1172-80
references.pmid: 8897823
references.citation: Dev Biol. 1999 Aug 15;212(2):307-22
references.pmid: 10433823
references.citation: Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H759-68
references.pmid: 15471974
references.citation: Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H947-59
references.pmid: 15833801
references.citation: Chest. 2005 Aug;128(2):787-91
references.pmid: 16100168
references.citation: Circulation. 2005 Oct 4;112(14):2108-13
references.pmid: 16203926
references.citation: Nature. 2005 Dec 8;438(7069):820-7
references.pmid: 16341007
references.citation: Am J Pathol. 2006 Feb;168(2):639-48
references.pmid: 16436677
references.citation: Microsc Res Tech. 2006 Feb;69(2):138-47
references.pmid: 16456839
references.citation: FASEB J. 2006 Mar;20(3):479-81
references.pmid: 16423874
references.citation: J Cell Mol Med. 2006 Jan-Mar;10(1):45-55
references.pmid: 16563221
references.citation: Circ Res. 2006 Apr 14;98(7):947-53
references.pmid: 16527987
references.citation: J Vasc Surg. 2006 Jul;44(1):166-75
references.pmid: 16753278
references.citation: Am J Cardiol. 2006 Nov 1;98(9):1194-7
references.pmid: 17056326
references.citation: FASEB J. 2006 Dec;20(14):2657-9
references.pmid: 17095533
references.citation: Development. 2000 Sep;127(18):3941-6
references.pmid: 10952892
references.citation: Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1890-7
references.pmid: 11009477
references.citation: Int J Cancer. 2000 Nov 20;89(6):475-83
references.pmid: 11102890
references.citation: Circulation. 2000 Dec 19;102(25):3098-103
references.pmid: 11120701
references.citation: Cancer Res. 2001 Feb 1;61(3):1207-13
references.pmid: 11221852
references.citation: Circ Res. 2001 Oct 26;89(9):779-86
references.pmid: 11679407
references.citation: Development. 2002 Apr;129(8):1881-92
references.pmid: 11934854
references.citation: Nat Med. 2002 Aug;8(8):841-9
references.pmid: 12091880
references.citation: J Korean Med Sci. 2002 Oct;17(5):581-8
references.pmid: 12378005
references.citation: Genes Dev. 2002 Oct 15;16(20):2684-98
references.pmid: 12381667
references.citation: Br J Cancer. 2002 Nov 4;87(10):1057-65
references.pmid: 12402142
references.citation: Circ Res. 2003 Mar 7;92(4):378-85
references.pmid: 12600898
references.citation: Circulation. 2003 May 6;107(17):2213-20
references.pmid: 12707241
references.citation: Nat Med. 2003 Jun;9(6):669-76
references.pmid: 12778165